Shares of the health and wellness platform operator skyrocketed more than 670% between Jan. 1, 2024, and Feb. 19, 2025.
That’s how long it’s been since Tom Izzo last hoisted a national championship trophy and apparently, the last time he’s felt anything.
Hims & Hers Health (NYSE:HIMS) has taken investors on a wild ride in 2025. The stock surged nearly 200% earlier this year, reaching an ...
Health care companies slid as traders retreated from high-risk issues. Shares of obesity-drug maker Novo Nordisk and Hims & Hers Health, the compounding pharmacy seeking to compete with the ...
The Mary Sue on MSN5d
Prince Andrew set for more humiliation as judges rule witness statement containing ‘embarrassing’ information should be releasedA tribunal has decided that a witness statement made by one of Prince Andrew’s aides should be made public despite the fact ...
Learn more about whether Alignment Healthcare, Inc. or Hims & Hers Health, Inc. is a better investment based on AAII's A+ ...
Learn more about whether Hims & Hers Health, Inc. or LifeStance Health Group, Inc. is a better investment based on AAII's A+ ...
Listen… We are always on the hunt for a deal. Clothes, restaurants, travel, whatever — if there’s a deal out there, we’ll ...
While swiping left and right have become synonymous with dating culture among younger generations, a 2025 Hims study found ...
Hims & Hers is shifting towards personalized medicine with AI-backed solutions. Find out why HIMS stock is buyable despite ...
The knockoff surge was led by Hims & Hers Health, the telehealth firm that began selling the drugs last spring.
Hims reveals that while swiping left and right have become synonymous with dating culture among younger generations, the vast ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback